Boditech Med Inc. (KOSDAQ:206640)
15,900
+410 (2.65%)
Apr 1, 2025, 3:30 PM KST
Boditech Med Revenue
In the year 2024, Boditech Med had annual revenue of 138.16B KRW with 2.94% growth. Boditech Med had revenue of 31.22B in the quarter ending December 31, 2024, a decrease of -10.60%.
Revenue
138.16B
Revenue Growth
+2.94%
P/S Ratio
2.52
Revenue / Employee
281.39M
Employees
491
Market Cap
346.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 138.16B | 3.94B | 2.94% |
Dec 31, 2023 | 134.22B | 16.14B | 13.67% |
Dec 31, 2022 | 118.08B | -39.63B | -25.13% |
Dec 31, 2021 | 157.71B | 13.58B | 9.42% |
Dec 31, 2020 | 144.13B | 71.33B | 97.99% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |